(Q34399765)

1 August 2017

Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy (English)

1 reference

1 August 2017

1 reference

Pierre G Coulie

1

1 reference

1 August 2017

Benoît J Van den Eynde

series ordinal

2

1 reference

1 August 2017

Pierre van der Bruggen

series ordinal

3

1 reference

1 August 2017

Thierry Boon

series ordinal

4

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 February 2014

1 reference

1 August 2017

Nature Reviews Cancer

1 reference

1 August 2017

14

1 reference

1 August 2017

135-146

1 reference

1 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc3670

1 August 2017

0 references

cites work

Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: contrasting consequences of host versus tumor evolution

1 reference

A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin

31 March 2020

1 reference

Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line

31 March 2020

1 reference

Teratocarcinoma cell variants rejected by syngeneic mice: protection of mice immunized with these variants against other variants and against the original malignant cell line

31 March 2020

1 reference

Protection against a nonimmunogenic mouse leukemia by an immunogenic variant obtained by mutagenesis

31 March 2020

1 reference

Thymus-marrow cell combinations. Synergism in antibody production

31 March 2020

1 reference

The Thymus and the Precursors of Antigen Reactive Cells

31 March 2020

1 reference

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice

31 March 2020

1 reference

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis

31 March 2020

1 reference

Long term culture of tumour-specific cytotoxic T cells

31 March 2020

1 reference

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response

31 March 2020

1 reference

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. VI. Occasional escape from host rejection due to antigen-loss secondary variants

31 March 2020

1 reference

Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression

31 March 2020

1 reference

Cancer immunoediting: from immunosurveillance to tumor escape

31 March 2020

1 reference

Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

31 March 2020

1 reference

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides

31 March 2020

1 reference

Structure of the human class I histocompatibility antigen, HLA-A2

31 March 2020

1 reference

Selection of highly transfectable variant from mouse mastocytoma P815.

31 March 2020

1 reference

Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation

31 March 2020

1 reference

Structure of the gene of tum- transplantation antigen P91A: the mutated exon encodes a peptide recognized with Ld by cytolytic T cells

31 March 2020

1 reference

Structure of the gene of tum- transplantation antigen P198: a point mutation generates a new antigenic peptide

31 March 2020

1 reference

The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice

31 March 2020

1 reference

Genes coding for tumor-specific rejection antigens

31 March 2020

1 reference

The shared tumor-specific antigen encoded by mouse gene P1A is a target not only for cytolytic T lymphocytes but also for tumor rejection

31 March 2020

1 reference

Cell-mediated cytotoxicity for cultured autologous melanoma cells

31 March 2020

1 reference

Specificity of auto-tumor cytotoxicity exerted by fresh, activated and propagated human T lymphocytes

31 March 2020

1 reference

Specific cytotoxicity against autologous tumour and proliferative responses of human lymphocytes grown in interleukin 2

31 March 2020

1 reference

T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures

31 March 2020

1 reference

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

31 March 2020

1 reference

Production of stable cytolytic T-cell clones directed against autologous human melanoma

31 March 2020

1 reference

Presence on a human melanoma of multiple antigens recognized by autologous CTL.

31 March 2020

1 reference

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

31 March 2020

1 reference

Major histocompatibility complex expression on human, male germ cells: a review

31 March 2020

1 reference

A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E

31 March 2020

1 reference

Structure, chromosomal localization, and expression of 12 genes of the MAGE family

31 March 2020

1 reference

Two members of the human MAGEB gene family located in Xp21.3 are expressed in tumors of various histological origins

31 March 2020

1 reference

Isolation and characterization of a MAGE gene family in the Xp21.3 region

31 March 2020

1 reference

MAGE-B5, MAGE-B6, MAGE-C2, andMAGE-C3: four new members of theMAGE family with tumor-specific expression

31 March 2020

1 reference

BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes

31 March 2020

1 reference

A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma

31 March 2020

1 reference

A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma

31 March 2020

1 reference

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

31 March 2020

1 reference

A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma

31 March 2020

1 reference

A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes

31 March 2020

1 reference

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

31 March 2020

1 reference

Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes

31 March 2020

1 reference

Human neoplasms elicit multiple specific immune responses in the autologous host

31 March 2020

1 reference

The SSX family of cancer-testis antigens as target proteins for tumor therapy

31 March 2020

1 reference

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

31 March 2020

1 reference

Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells

31 March 2020

1 reference

Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

31 March 2020

1 reference

An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins

31 March 2020

1 reference

An antigenic peptide produced by reverse splicing and double asparagine deamidation

31 March 2020

1 reference

A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3.

31 March 2020

1 reference

Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes

31 March 2020

1 reference

Tumor-specific shared antigenic peptides recognized by human T cells

31 March 2020

1 reference

Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine

31 March 2020

1 reference

Immunotherapy for Epstein-Barr virus-associated malignancies.

31 March 2020

1 reference

Therapeutic vaccination against human papilloma virus induced malignancies

31 March 2020

1 reference

Adoptive cellular immunotherapy for viral diseases

31 March 2020

1 reference

Newly emerging therapies targeting viral-related lymphomas

31 March 2020

1 reference

The response of autologous T cells to a human melanoma is dominated by mutated neoantigens

31 March 2020

1 reference

Comprehensive molecular characterization of human colon and rectal cancer

31 March 2020

1 reference

A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma.

31 March 2020

1 reference

Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia

31 March 2020

1 reference

Cytotoxic T cell response against the chimeric ETV6-AML1 protein in childhood acute lymphoblastic leukemia

31 March 2020

1 reference

Leukemia-associated fusion proteins, dek-can and bcr-abl, represent immunogenic HLA-DR-restricted epitopes recognized by fusion peptide-specific CD4+ T lymphocytes

31 March 2020

1 reference

Augmentation of immune response by altered peptide ligands of the antigenic peptide in a human CD4+ T-cell clone reacting to TEL/AML1 fusion protein

31 March 2020

1 reference

Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells

31 March 2020

1 reference

The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.

31 March 2020

1 reference

Frequent DNA hypomethylation of human juxtacentromeric BAGE loci in cancer

31 March 2020

1 reference

MAGE-A1, GAGE and NY-ESO-1 cancer/testis antigen expression during human gonadal development.

31 March 2020

1 reference

Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes

31 March 2020

1 reference

A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

31 March 2020

1 reference

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

31 March 2020

1 reference

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor

31 March 2020

1 reference

Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-A2.1-restricted anti-melanoma CTL line

31 March 2020

1 reference

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection

31 March 2020

1 reference

High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals

31 March 2020

1 reference

Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen

31 March 2020

1 reference

Estimation of the frequencies of anti-MAGE-3 cytolytic T-lymphocyte precursors in blood from individuals without cancer.

31 March 2020

1 reference

Enumeration of human antigen-specific naive CD8+ T cells reveals conserved precursor frequencies

31 March 2020

1 reference

Thymic selection generates a large T cell pool recognizing a self-peptide in humans

31 March 2020

1 reference

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes

31 March 2020

1 reference

In vitro generation of human cytotoxic T lymphocytes specific for peptides derived from prostate-specific antigen

31 March 2020

1 reference

HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase

31 March 2020

1 reference

Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines

31 March 2020

1 reference

Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients

31 March 2020

1 reference

Transferred WT1-reactive CD8+ T cells can mediate antileukemic activity and persist in post-transplant patients

31 March 2020

1 reference

MUC1 immunobiology: from discovery to clinical applications

31 March 2020

1 reference

An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus

31 March 2020

1 reference

Medullary epithelial cells of the human thymus express a highly diverse selection of tissue-specific genes colocalized in chromosomal clusters

31 March 2020

1 reference

Minimal tolerance to a tumor antigen encoded by a cancer-germline gene.

31 March 2020

1 reference

Management of immune-related adverse events and kinetics of response with ipilimumab

31 March 2020

1 reference

Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy

31 March 2020

1 reference

Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma.

31 March 2020

1 reference

T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis.

31 March 2020

1 reference

Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience

31 March 2020

1 reference

Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study

31 March 2020

1 reference

Long-term follow-up of patients treated by adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma

31 March 2020

1 reference

Ocular and systemic autoimmunity after successful tumor-infiltrating lymphocyte immunotherapy for recurrent, metastatic melanoma

31 March 2020

1 reference

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

31 March 2020

1 reference

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

31 March 2020

1 reference

Nivolumab plus ipilimumab in advanced melanoma

31 March 2020

1 reference

Cancer immunotherapy: a treatment for the masses

31 March 2020

1 reference

Adoptive immunotherapy for cancer: building on success

31 March 2020

1 reference

High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens

31 March 2020

1 reference

Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen

31 March 2020

1 reference

Vaccination of a melanoma patient with mature dendritic cells pulsed with MAGE-3 peptides triggers the activity of nonvaccine anti-tumor cells

31 March 2020

1 reference

Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells

31 March 2020

1 reference

Human T cell responses against melanoma

31 March 2020

1 reference

Immune resistance orchestrated by the tumor microenvironment

31 March 2020

1 reference

Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules.

31 March 2020

1 reference

Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells

31 March 2020

1 reference

The production of a new MAGE-3 peptide presented to cytolytic T lymphocytes by HLA-B40 requires the immunoproteasome

31 March 2020

1 reference

Destructive cleavage of antigenic peptides either by the immunoproteasome or by the standard proteasome results in differential antigen presentation

31 March 2020

1 reference

Analysis of the processing of seven human tumor antigens by intermediate proteasomes.

31 March 2020

1 reference

Immune recognition of a human renal cancer antigen through post-translational protein splicing.

31 March 2020

1 reference

An antigenic peptide produced by peptide splicing in the proteasome

31 March 2020

1 reference

Production of an antigenic peptide by insulin-degrading enzyme

31 March 2020

1 reference

Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes

31 March 2020

1 reference

The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28

31 March 2020

1 reference

MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases

31 March 2020

1 reference

MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents

31 March 2020

1 reference

MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines

31 March 2020

1 reference

Melanoma antigen gene protein MAGE-11 regulates androgen receptor function by modulating the interdomain interaction

31 March 2020

1 reference

Induced malignant genome reprogramming in somatic cells by testis-specific factors

31 March 2020

1 reference

MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription

31 March 2020

1 reference

MAGE-A4 interacts with the liver oncoprotein gankyrin and suppresses its tumorigenic activity

31 March 2020

1 reference

Melanoma antigen A4 is expressed in non-small cell lung cancers and promotes apoptosis

31 March 2020

1 reference

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

31 March 2020

1 reference

A MAGE-A4 peptide presented by HLA-A2 is recognized by cytolytic T lymphocytes

31 March 2020

1 reference

A tumor-infiltrating lymphocyte from a melanoma metastasis with decreased expression of melanoma differentiation antigens recognizes MAGE-12.

31 March 2020

1 reference

Two new tumor-specific antigenic peptides encoded by gene MAGE-C2 and presented to cytolytic T lymphocytes by HLA-A2.

31 March 2020

1 reference

New BAGE (B melanoma antigen) genes mapping to the juxtacentromeric regions of human chromosomes 13 and 21 have a cancer/testis expression profile.

31 March 2020

1 reference

BAGE genes generated by juxtacentromeric reshuffling in the Hominidae lineage are under selective pressure.

31 March 2020

1 reference

An overview of the GAGE cancer/testis antigen family with the inclusion of newly identified members

31 March 2020

1 reference

The XAGE family of cancer/testis-associated genes: alignment and expression profile in normal tissues, melanoma lesions and Ewing's sarcoma

31 March 2020

1 reference

Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes

31 March 2020

1 reference

Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library

31 March 2020

1 reference

The SSX gene family: characterization of 9 complete genes

31 March 2020

1 reference

31 March 2020

1 reference

Functional domains of the SYT and SYT-SSX synovial sarcoma translocation proteins and co-localization with the SNF protein BRM in the nucleus

31 March 2020

1 reference

Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma

31 March 2020

1 reference

Function of the A-type cyclins during gametogenesis and early embryogenesis

31 March 2020

1 reference

Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen

31 March 2020

1 reference

Identification of a new cancer/germline gene, KK-LC-1, encoding an antigen recognized by autologous CTL induced on human lung adenocarcinoma

31 March 2020

1 reference

The centrosomal localization of KM-HN-1 (MGC33607) depends on the leucine zipper motif and the C-terminal coiled-coil domain.

31 March 2020

1 reference

Identification of a novel human cancer/testis antigen, KM-HN-1, recognized by cellular and humoral immune responses

31 March 2020

1 reference

Determination of cellularly processed HLA-A2402-restricted novel CTL epitopes derived from two cancer germ line genes, MAGE-A4 and SAGE

31 March 2020

1 reference

Sperm protein 17 is a novel cancer-testis antigen in multiple myeloma

31 March 2020

1 reference

A re-evaluation of sperm protein 17 (Sp17) indicates a regulatory role in an A-kinase anchoring protein complex, rather than a unique role in sperm-zona pellucida binding

31 March 2020

1 reference

Identification of a sperm protein 17 CTL epitope restricted by HLA‐A1

31 March 2020

1 reference

A new member of the NY-ESO-1 gene family is ubiquitously expressed in somatic tissues and evolutionarily conserved

31 March 2020

1 reference

Expression and immunotherapeutic targeting of the SSX family of cancer-testis antigens in prostate cancer

31 March 2020

1 reference

The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens

31 March 2020

1 reference

Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene

31 March 2020

1 reference

LAGE-1, a new gene with tumor specificity

31 March 2020

1 reference

A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene

31 March 2020

1 reference

Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen

31 March 2020

1 reference

Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage

31 March 2020

1 reference

A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcription

31 March 2020

1 reference

Interleukin-2-induced, melanoma-specific T cells recognize CAMEL, an unexpected translation product of LAGE-1.

31 March 2020

1 reference

An alternative open reading frame of the human macrophage colony-stimulating factor gene is independently translated and codes for an antigenic peptide of 14 amino acids recognized by tumor-infiltrating CD8 T lymphocytes

31 March 2020

1 reference

A member of the GAGE family of tumor antigens is an anti-apoptotic gene that confers resistance to Fas/CD95/APO-1, Interferon-gamma, taxol and gamma-irradiation

31 March 2020

1 reference

12 December 2020

Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs.

1 reference

12 December 2020

Structure of the gene of tum- transplantation antigen P35B: presence of a point mutation in the antigenic allele

1 reference

12 December 2020

The Murine Sarcoma Virus-Induced Tumor: Exception or General Model in Tumor Immunology?

1 reference

12 December 2020

Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells

1 reference

12 December 2020

Characterization of a second human cyclin A that is highly expressed in testis and in several leukemic cell lines

1 reference

12 December 2020

Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine.

1 reference

12 December 2020

Recognition of BCR-ABL positive leukemic blasts by human CD4+ T cells elicited by primary in vitro immunization with a BCR-ABL breakpoint peptide

1 reference

12 December 2020

The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40

1 reference

12 December 2020

Quantitative studies on phytohaemagglutinin-induced cytotoxicity by human lymphocytes against homologous cells in tissue culture

1 reference

12 December 2020

A new MAGE gene with ubiquitous expression does not code for known MAGE antigens recognized by T cells.

1 reference

12 December 2020

Human CD4 lymphocytes specifically recognize a peptide representing the fusion region of the hybrid protein pml/RAR alpha present in acute promyelocytic leukemia cells

1 reference

12 December 2020

Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains.

1 reference

12 December 2020

Identification of DR9-restricted XAGE antigen on lung adenocarcinoma recognized by autologous CD4 T-cells

1 reference

12 December 2020

Cell-mediated cytotoxicity, allograft rejection, and tumor immunity

1 reference

12 December 2020

Identification on a human sarcoma of two new genes with tumor-specific expression

1 reference

12 December 2020

Characterization of overlapping XAGE-1 transcripts encoding a cancer testis antigen expressed in lung, breast, and other types of cancers

1 reference

12 December 2020

Anti-theta serum-induced supression of the cellular transfer of tumour-specific immunity to a syngeneic plasma cell tumour.

1 reference

12 December 2020

MAGE-B5, MAGE-B6, MAGE-C2, and MAGE-C3: four new members of the MAGE family with tumor-specific expression

1 reference

12 December 2020

Immunity to methylcholanthrene-induced sarcomas

1 reference

12 December 2020

Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1.

1 reference

12 December 2020

An overview of the MAGE gene family with the identification of all human members of the family

1 reference

12 December 2020

The tumor dormant state

1 reference

12 December 2020

Identification of a new MAGE gene with tumor-specific expression by representational difference analysis

1 reference

12 December 2020

Multiple lineages of tumors express a common tumor antigen, P1A, but they are not cross-protected.

1 reference

12 December 2020

Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia

1 reference

12 December 2020

HLA class I-restricted lysis of leukemia cells by a CD8(+) cytotoxic T-lymphocyte clone specific for WT1 peptide

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRC3670

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference